The number of active cases in the country is now down to only 27,115 after 17,727 more patients recovered from the coronavirus disease (COVID-19) based on the latest data released Sunday by the Department of Health (DOH).
The new recoveries brought the total number of COVID-19 survivors to 348,760.
The DOH also reported 2,396 new confirmed cases, raising the country's cumulative caseload to 383,113. It said 7.1 percent of the total caseload or 27,115 are active cases or patients still undergoing treatment.
Of these active cases, 81.6 percent experienced mild symptoms, 9.9 percent were asymptomatic, 5.4 percent were in critical condition, and 3.1 percent experienced severe symptoms.
Davao City was identified as the top area with the most number of new infections at 148, followed by Quezon City with 146, Laguna with 122, Cavite with 112, and Benguet with 100.
Meanwhile, 17 more deaths were also reported, raising the death toll to 7,238, the DOH said.
Unregistered COVID-19 vaccines
Meanwhile, Food and Drug Administration (FDA) Director-General Rolando Enrique Domingo urged the public to report those who are offering vaccines for COVID-19.
Domingo stressed that there remains no approved vaccine for COVID-19 yet in the country.
“We just want to remind everybody that there still no registered COVID-19 vaccines in the Philippines,” he said.
“Kung meron po kayong nakikitang naga-advertise, nagbebenta at sinasabing meron na, please report them directly to us ,” he added.
The online reporting facility of the FDA may be accessed through its official website.
“You can inform us so that we can have those facilities inspected and checked dahil iligal po ang pagbenta ng COVID-19 vaccines ,” said Domingo.
The FDA official also noted that those who are eyeing to conduct clinical trials in the country cannot sell their products.
“Even if there would be clinical trials in the Philippines, they cannot be promoted as safe and effective and, definitely, they cannot be sold. Any investigational product cannot be sold in the market,” said Domingo.